Cibc World Market Inc. grew its stake in Waters Corporation (NYSE:WAT – Free Report) by 151.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,327 shares of the medical instruments supplier’s stock after purchasing an additional 9,242 shares during the period. Cibc World Market Inc.’s holdings in Waters were worth $6,735,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Pilgrim Global Advisors LLC bought a new stake in Waters in the 2nd quarter worth approximately $466,131,171,000. BlackRock Inc. purchased a new position in shares of Waters in the second quarter valued at $3,182,191,000. State Street Corp increased its stake in Waters by 0.5% during the second quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier’s stock worth $1,643,428,000 after acquiring an additional 19,998 shares during the last quarter. Aberdeen Group plc raised its position in Waters by 2,015.3% in the 3rd quarter. Aberdeen Group plc now owns 2,921,255 shares of the medical instruments supplier’s stock worth $1,283,570,000 after purchasing an additional 2,783,151 shares during the period. Finally, Jupiter Topco LLC purchased a new stake in shares of Waters during the second quarter valued at $623,921,000. Institutional investors own 94.01% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages recently issued reports on WAT. Sanford C. Bernstein restated an “outperform” rating and set a $535.00 price target on shares of Waters in a research note on Wednesday, November 4th. HSBC boosted their target price on shares of Waters from $450.00 to $455.00 and gave the stock a “buy” rating in a research report on Tuesday, September 1st. Guggenheim raised their price objective on Waters from $440.00 to $490.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Jefferies Financial Group upped their target price on Waters from $450.00 to $455.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Wells Fargo & Company boosted their price target on Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $475.48.
Waters Price Performance
NYSE:WAT opened at $439.73 on Friday. The business’s 50-day moving average price is $445.18 and its 200 day moving average price is $376.00. The firm has a market cap of $43.22 billion, a P/E ratio of 188.73, a PEG ratio of 2.50 and a beta of 1.16. The company has a quick ratio of 1.28, a current ratio of 1.89 and a debt-to-equity ratio of 0.29. Waters Corporation has a 52-week low of $282.77 and a 52-week high of $483.33.
Waters (NYSE:WAT – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.00 by $0.10. The business had revenue of $1.77 billion for the quarter, compared to analyst estimates of $1.75 billion. Waters had a net margin of 1.75% and a return on equity of 9.91%. Waters’s revenue was up 120.9% compared to the same quarter last year. During the same period last year, the business posted $3.40 EPS. As a group, sell-side analysts predict that Waters Corporation will post 14.65 earnings per share for the current fiscal year.
About Waters
Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples. The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.
Featured Articles
- Five stocks we like better than Waters
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
